What are research peptides? — a beginner's guide
A plain English explainer on what research peptides are, how they differ from approved medicines, why people use them, and what the legal status is.
Peptides are short chains of amino acids — the same building blocks that make up proteins. Your body naturally produces hundreds of peptides that act as signalling molecules, telling cells what to do. Research peptides are synthetic versions of these naturally occurring compounds, or modified analogues designed to target specific receptors.
How are they different from approved medicines?
Approved medicines like Ozempic (semaglutide) and Mounjaro (tirzepatide) are also peptides — but they have completed Phase 3 clinical trials, received regulatory approval, and are prescribed by doctors for specific conditions. Research peptides have not completed this approval process. They are sold legally for research purposes, not for human therapeutic use.
Why do people research them?
People research peptides for a wide range of purposes — weight loss, injury recovery, muscle development, skin health, longevity and anti-aging. The most commonly researched compounds are BPC-157 (tissue repair), the GLP-1 class (weight loss and metabolic health), and growth hormone secretagogues like CJC-1295 and Ipamorelin.
Are they safe?
Most research peptides have extensive preclinical (animal model) data and some have Phase 1 or Phase 2 human trial data. The safety profile varies by compound. Generally, peptides derived from naturally occurring sequences have good safety profiles in preclinical literature. However, because most have not completed Phase 3 trials, long-term human safety data is limited.
Where to start
If you are new to peptide research, we recommend starting with the most well-researched compounds in the area you are interested in. For recovery research, BPC-157 and TB-500 have the deepest literature. For weight loss research, the GLP-1 class compounds are the most extensively studied.